4//SEC Filing
KASH PETER M 4
Accession 0000914190-11-000421
CIK 0001133869other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:47 AM ET
Size
21.3 KB
Accession
0000914190-11-000421
Insider Transaction Report
Form 4
KASH PETER M
Director
Transactions
- Other
Warrant (Right to Buy)
2011-07-18+19,500→ 19,500 totalExercise: $0.60From: 2011-07-18Exp: 2016-07-18→ Common Stock (19,500 underlying)
Holdings
- 496,589(indirect: By Spouse)
Common Stock
- 1,052
Warrant (Right to Buy)
Exercise: $2.71From: 2007-09-17Exp: 2011-09-17→ Common Stock (1,052 underlying) - 60,000
Stock Option (Right to Buy)
Exercise: $4.50Exp: 2018-01-25→ Common Stock (60,000 underlying) - 125,000
Warrant (Right to Buy)
Exercise: $1.38From: 2009-07-15Exp: 2019-07-15→ Common Stock (125,000 underlying) - 80,000
Stock Option (Right to Buy)
Exercise: $0.73From: 2012-05-10Exp: 2021-05-10→ Common Stock (80,000 underlying) - 24,703
Warrant (Right to Buy)
Exercise: $1.71From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,703 underlying) - 1,596,208
Common Stock
- 35,000
Stock Option (Right to Buy)
Exercise: $0.93From: 2010-01-01Exp: 2018-12-22→ Common Stock (35,000 underlying) - 80,000
Stock Option (Right to Buy)
Exercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying) - 24,704
Warrant (Right to Buy)
Exercise: $1.25From: 2009-07-07Exp: 2014-07-07→ Common Stock (24,704 underlying) - 165,530(indirect: By Foundation)
Common Stock
- 80,000
Stock Option (Right to Buy)
Exercise: $1.77From: 2010-07-21Exp: 2019-07-21→ Common Stock (80,000 underlying) - 49,407
Warrant (Right to Buy)
Exercise: $2.28From: 2009-07-07Exp: 2014-07-07→ Common Stock (49,407 underlying)
Footnotes (3)
- [F1]Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- [F2]Fully exercisable.
- [F3]The Reporting Person received the warrant as a designee of Riverbank Capital Securities, Inc., which served as a placement agent for the Issuer's June 2011 private placement.
Documents
Issuer
Nile Therapeutics, Inc.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001253023
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 9:47 AM ET
- Size
- 21.3 KB